Home›Companies›Healthcare›Credence MedSystems

Credence MedSystems, Inc.

Makes injectable drug delivery devices for pharmaceutical and biotechnology manufacturers.

Updated Nov 10, 2026·Latest SEC filing Jun 22, 2026·Suggest an edit

About Credence MedSystems

Credence MedSystems is a private company based in Menlo Park, California. It has reported $93,044,217 raised in six offerings on Form D since October 2012. Its chief executive is Jeff Tillack.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 17, 2024Dec 30, 2024amended Jun 22, 2026$23,505,661of $30.0M target76$309KEquityRule 506(b)Form D/A ↗1 earlier filing
Apr 24, 2020May 7, 2020amended Sep 22, 2021$39,869,191of $40.0M target115$346KEquityRule 506(b)Form D/A ↗3 earlier filings
Mar 8, 2018Mar 22, 2018amended Jul 19, 2018$12,759,548of $14.0M target82$155KEquityRule 506(b)Form D/A ↗1 earlier filing
Apr 6, 2016Apr 21, 2016$7,909,817of $17.7M target5$1.5MEquityRule 506(b)Form D ↗
Aug 26, 2013Sep 25, 2013$6,000,000fully sold4$1.5MEquityRule 506(b)Form D ↗
Sep 24, 2012Oct 9, 2012$3,000,000fully sold35$85,714Equity06Form D ↗
Total, six offerings$93,044,217

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Credence MedSystems's Form D filed Jun 22, 2026.

FL
Frank Litvack
Chairman of the Board of Directors
BH
Ben Hall
Director
BW
Brian Webber
Director
RS
JS
John Shanley
Executive officer and director
RB
Robert Beart
Director

Sources

  1. SECCredence MedSystems, Inc. Form D, filed Dec 30, 2024
  2. SECCredence MedSystems, Inc. Form D/A, filed Jul 2, 2021
  3. SECCredence MedSystems, Inc. Form D/A, filed Nov 3, 2020
  4. SECCredence MedSystems, Inc. Form D, filed May 7, 2020
  5. SECCredence MedSystems, Inc. Form D, filed Mar 22, 2018
  6. SECCredence MedSystems, Inc. filing history
  7. CompanyLeadership